Warren Buffett Pays This Much Into Social Security Each Year
It's probably less than you think.
Vape-Related Health Concerns May Be a Real Problem for These Pot Stocks
More than 450 cases of mysterious lung illnesses, along with five deaths, have been reported across 33 states.
2 Recession-Ready Stocks to Buy Right Now
If a recession hits in 2019 or 2020, these stocks should do better than most.
As global demand for oil and natural gas continues to grow, Big Energy will continue meeting that demand while also investing in the future. Where should you put your money?
Shares slump after a pair of clinical studies raises new questions about the safety and cost-effectiveness of Abiomed's family of heart pumps. Here are the must-know details.
A lower profit outlook for the year didn't go over well with investors.
The small-cap biopharma inked a deal with a major pharmaceutical company, its second in three weeks.
So much for Disney's claims that their new streaming subscription service would be "ad free."
The reason is pretty simple.
A collaboration with Alphabet's YouTube Music has investors excited.
Older Americans must prepare for the biggest increase in Part B premiums in three years.
The busiest shopping day of the year could be a quieter affair this holiday season.
One of the world's biggest gaming franchises has successfully expanded to mobile, but there's still a crucial hurdle on the horizon.
Consumers may get a trifecta of services from the iPhone maker for one low price.
Despite falling 12%, the stock is still receiving aggressive valuations. Are there any cheaper options with similar macro exposure?
AT&T's latest earnings report and the unveiling of HBO Max should reassure investors this behemoth is heading in the right direction.
The clinical-stage biopharmaceutical company announced really great phase 2 results for its lead pipeline candidate.
Let's take a closer look at the industrial giant's stock valuation.
Markets moved lower Monday morning.
An overseas telco giant, former marijuana highflier, and dental products IPO are hitting fresh 52-week lows.
Is the optimism surrounding this insulin pump maker justified?
Top investors oversee billions' worth of assets for a reason, so why not check out what they are buying?
Following third-quarter results above ambitious expectations, the company's market capitalization increased by more than $1.9 billion overnight.